Chagas' disease: Lessons from routine donation testing

Transfusion Medicine

Volumn 19, Issue 1, 2009, Pages 16-23

  Castro, E ^a  

^a Centro de Transfusion de Cruz Roja Espanola   (Spain)

Author keywords

Blood donor deferral; Chagas' disease; Parasites; T. cruzi

Indexed keywords

PROTOZOON ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; BLOOD DONOR; CHAGAS DISEASE; CHRONIC DISEASE; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION TEST; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LEUKAPHERESIS; NONHUMAN; REVIEW; TRYPANOSOMA CRUZI;

BLOOD DONORS; BLOOD TRANSFUSION; CHAGAS DISEASE; DONOR SELECTION; HUMANS; MASS SCREENING;

EID: 62549125964     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2009.00915.x     Document Type: Review

References (53)

1. Abalo, M., Adelantado, M., Areal, C. et al 2007) Tracing of one year of Chagas screening at the Centro de Transfusion de Galicia (C.T.G.) concerning a positive blood donor (abstract). Vox Sanguinis, 93, 140.
2. Appleman, M.D., Shulman, I.A., Saxena, S. Kirchhoff, L.V. (1993) Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi. Transfusion, 33, 61 64.
3. Assal, A. Aznar, C 2007) Chagas' disease screening in the French blood donor population. Screening assays and donor selection. Enfermedades Emergentes, 9, 36 40.
4. Barrett, M.P., Burchmore, R.J., Stich, A., Lazzari, J.O., Frasch, A.C., Cazzulo, J.J. Krishna, S 2003) The trypanosomiases. Lancet, 362, 1469 1480.
5. Cardo, L.J., Salata, J., Mendez, J., Reddy, H. Goodrich, R 2007) Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfusion and Apheresis Science, 37, 131 137.
6. Castro, E 2006) Transfusión sanguínea y enfermedad de Chagas. Enfermedades Emergentes, 8, 48 50.
7. Castro, E., Girones, N., Bueno, J.L., Carrion, J., Lin, L. Fresno, M 2007) The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion, 47, 434 441.
8. Castro, E., Girones, N., Guerrero, N.A., Barea, L. Fresno, M 2008) The effectiveness of UVC pathogen inactivation system on reducing the Trypanosoma cruzi and Leishmania Infantum burden in platelets (abstract). Vox Sanguinis, 95 (Suppl. 1 290.
9. CDC (2001) Chagas disease after organ transplantation - United Sates. MMWR Morbidity and Mortality Weekly Report, 51, 210 212.
10. CDC (2006) Chagas disease after organ transplantation - Los Angeles, California. MMWR Morbidity and Mortality Weekly Report, 55, 800.
11. CDC (2007) Blood donor screening for Chagas' disease United States, 2006-2007. MMWR Morbidity and Mortality Weekly Report, 56, 141 143.
12. Chang, C.D., Cheng, K.Y., Jiang, L.X. et al 2006) Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening. Transfusion, 46, 1737 1744.
13. Cimo, P.L., Luper, W.E. Scouros, M.A 1993) Transfusion-associated Chagas' disease in Texas: report of a case. Texas Medicine, 89, 48 50.
14. Custer, S., Kamel, H.T., Tomasulo, P.A., Murphy, E.L. Busch, M.P 2008) 10-month experience screening USA blood donors for Trypanosoma cruzi: yield, risk factors, and cost effectiveness. Vox Sanguinis, 95, 39.
15. Flores-Chavez, M., de Fuentes, I., Garate, T. Canavate, C 2007) Diagnóstico de laboratorio de la enfermedad de Chagas importada. Enfermedades Infecciosas y Microbiologia Clinica, 25, 29 37.
16. Flores-Chavez, M., Fernandez, B., Puente, S. et al 2008) Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clinical Infectious Diseases, 46, e44 e47.
17. Fores, R., Sanjuan, I., Portero, F. et al 2007) Chagas disease in a recipient of cord blood transplantation. Bone Marrow Transplantation, 39, 127 128.
18. Gadelha, A.A., Vercosa, A.F., Lorena, V.M. et al 2003) Chagas' disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test. Vox Sanguinis, 85, 165 170.
19. Garraud, O., Andreu, G., Elghouzzi, M.H., Laperche, S. Lefrere, J.J 2007) Measures to prevent transfusion-associated protozoal infections in non-endemic countries. Travel Medicine and Infectious Disease, 5, 110 112.
20. Garraud, O., Pelletier, B. Aznar, C 2008) Why defer blood donor candidates because of an exposure risk to Chagas disease?. Transfusion Clinique et Biologique, 15, 123 128.
21. Girones, N., Bueno, J.L., Carrion, J., Fresno, M. Castro, E 2006) The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma. Vox Sanguinis, 91, 285 291.
22. Grant, I.H., Gold, J.W., Wittner, M. et al 1989) Transfusion-associated acute Chagas disease acquired in the United States. Annals of Internal Medicine, 111, 849 851.
23. Instituto Nacional de Estadística (2008) Spain census data (database on the internet). INE, Madrid.
24. Lane, D.J., Sher, G. Ward, B 2000) Investigation of the second case of transfusion transmitted Chagas disease in Canada (abstract). Blood, 96, 60A.
25. Leiby, D.A., Fucci, M.H. Stumpf, R.J 1999a) Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission. Transfusion, 39, 310 315.
26. Leiby, D.A., Herron, R.M. Jr., Garratty, G. Herwaldt, B.L 2008) Trypanosoma cruzi Parasitemia in US blood donors with serologic evidence of infection. Journal of Infectious Diseases, 198, 609 613.
27. Leiby, D.A., Herron, R.M. Jr., Read, E.J., Lenes, B.A. Stumpf, R.J 2002) Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion, 42, 549 555.
28. Leiby, D.A., Lenes, B.A., Tibbals, M.A. Tames-Olmedo, M.T 1999b) Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. New England Journal of Medicine, 341, 1237 1239.
29. Leiby, D.A., Read, E.J., Lenes, B.A., Yund, A.J., Stumpf, R.J., Kirchhoff, L.V. Dodd, R.Y 1997) Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. Journal of Infectious Diseases, 176, 1047 1052.
30. Lewinsohn, R 1981) Carlos Chagas and the discovery of Chagas' disease (American trypanosomiasis). Journal of the Royal Society Of Medicine, 74, 451 455.
31. Ministry of Health (2005) Real Decreto 1088/2005 por el que se establecen los requisitos técnicos y condiciones mínimas de la hemodonación y de los centros y servicios de transfusión del 20 de septiembre de 2005. 225, 31288 31304.
32. Moncayo, A. Ortiz Yanine, M.I 2006) An update on Chagas disease (human American trypanosomiasis). Annals of Tropical Medicine and Parasitology, 100, 663 677.
33. Moraes-Souza, H., Bordin, J.O., Bardossy, L., MacPherson, D.W. Blajchman, M.A 1995) Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood. Transfusion, 35, 723 726.
34. Nickerson, P., Orr, P., Schroeder, M.L., Sekla, L. Johnston, J.B 1989) Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Annals of Internal Medicine, 111, 851 853.
35. O'Brien, S.F., Chiavetta, J.A., Fan, W., Xi, G., Yi, Q.L., Goldman, M., Scalia, V. Fearon, M.A 2008) Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion, 48, 755 761.
36. O'Brien, S.F., Ram, S.S., Vamvakas, E.C. Goldman, M 2007) The Canadian blood donor health assessment questionnaire: lessons from history, application of cognitive science principles, and recommendations for change. Transfusion Medicine Reviews, 21, 205 222.
37. Pedreira de Freitas, J.L., Amato Neto, V., Sonntag, R., Biancalana, A., Nussenszweig, V. Barreto, J.G 1952) Primeiras verificacoes de transmissao acidental da moléstia de Chagas ao homem por transfusao de sangue. Revista Paulista de Medicina, 40, 36 40.
38. Pirard, M., Iihoshi, N., Boelaert, M., Basanta, P., Lopez, F. Van der, S.P 2005) The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion, 45, 554 561.
39. Prata, A 2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infectious Diseases, 1, 92 100.
40. Reesink, H.W 2005) European strategies against the parasite transfusion risk. Transfusion Clinique et Biologique, 12, 1 4.
41. Saez-Alquezar, A., Sabino, E.C., Salles, N., Chamone, D.F., Hulstaert, F., Pottel, H., Stoops, E. Zrein, M 2000) Serological confirmation of Chagas' disease by a recombinant and peptide antigen line immunoassay: INNO-LIA Chagas. Journal of Clinical Microbiology, 38, 851 854.
42. Schmunis, G.A 1991) Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion, 31, 547 557.
43. Schmunis, G.A 2007a) Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Memorias do Instituto Oswaldo Cruz, 102 (Suppl. 1 75 85.
44. Schmunis, G.A 2007b) The globalization of Chagas disease. ISBT Science Series, 2, 6 11.
45. da Silveira, J.F., Umezawa, E.S. Luquetti, A.O 2001) Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends in Parasitology, 17, 286 291.
46. Shah, D.O., Chang, C.D., Cheng, K.Y. et al 2008) An immunoblot assay using recombinant antigens to confirm antibodies to Trypanosoma cruzi. Vox Sanguinis, 95, 281.
47. Stramer, L., Townsend, L., Foster, A. et al 2008) US blood donor screening for Trypanosoma cruzi: clinical studies and first year experience. Vox Sanguinis, 95, 296.
48. Umezawa, E.S., Nascimento, M.S., Kesper, N. Jr., Coura, J.R., Borges-Pereira, J., Junqueira, A.C. Camargo, M.E 1996) Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease. Journal of Clinical Microbiology, 34, 2143 2147.
49. Van Voorhis, W.C., Barrett, L.K., Eastman, R.T., Alfonso, R. Dupuis, K 2003) Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV. Antimicrobial Agents and Chemotherapy, 47, 475 479.
50. Wendel, S 2006) Transfusion-transmitted American and African trypanosomiasis (Chagas disease and sleeping sickness): neglected or reality? ISBT Science Series, 1, 140 151.
51. Winkler, M.A., Brashear, R.J., Hall, H.J., Schur, J.D. Pan, A.A 1995) Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II. Evaluation of a supplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of seroreactivity. Transfusion, 35, 219 225.
52. World Health Organization, Control of Chagas Disease (2002) Report of WHO Expert Committee. World Health Organization Technical Report Series, 905, 1 1209.
53. Young, C., Losikoff, P., Chawla, A., Glasser, L. Forman, E 2007) Transfusion-acquired Trypanosoma cruzi infection. Transfusion, 47, 540 544.